BGC Group, Inc. (BGC)

Theseus Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	826.47	711.58	655.64	484.99	553.6	596.29
Short-Term Investments	153.71	207.89	63.05	56.34	54.45	315.69
Accounts Receivable	1,489	697.03	658.55	849.6	1,083	1,055
Other Receivables	468.26	396.28	388.77	362.53	324.96	435.59
Property, Plant & Equipment	189.53	304.47	302.47	313.26	326.36	381.99
Goodwill	625.5	540.29	506.34	486.59	486.92	556.21
Other Intangible Assets	445.77	240.91	211.29	192.78	207.75	287.16
Investments in Debt & Equity Securities	43.57	136.03	85.75	83.83	82.29	82.46
Other Current Assets	-	32.49	30.4	34.66	32.56	51.57
Long-Term Deferred Tax Assets	-	273.3	215.54	152.39	135.37	125.29
Other Long-Term Assets	649.06	51.71	58.15	58	54.8	66.05
Total Assets	4,891	3,592	3,176	3,075	3,342	3,953
Accounts Payable	1,555	225.38	202.27	404.68	656.28	179.72
Accrued Expenses	308.04	404.68	388.75	376.75	418.32	1,112
Short-Term Debt	-	-	-	1.92	3.58	3.85
Current Portion of Long-Term Debt	-	299.29	299.2	449.24	-	255.57
Current Portion of Leases	-	31.24	-	-	-	-
Long-Term Debt	1,918	1,038	884.31	599.97	1,053	1,060
Long-Term Leases	-	107.83	154.36	162.14	169.21	190.21
Long-Term Deferred Tax Liabilities	-	12.7	25.17	21.26	18.14	24.32
Other Long-Term Liabilities	0.84	42.2	30.2	19.71	63.8	39.68
Total Liabilities	3,782	2,513	2,278	2,326	2,660	3,121
Common Stock	5.46	5.34	5.13	5.18	4.82	4.19
Additional Paid-In Capital	2,403	2,311	2,105	2,559	2,451	2,375
Retained Earnings	-933.21	-1,026	-1,119	-1,138	-1,172	-1,281
Comprehensive Income & Other	-41.07	-59.85	-38.58	-45.43	-40.55	-28.93
Total Common Equity	930.46	898.51	885.08	669.65	619.75	754.24
Minority Interest	178.22	180.73	13.07	79.08	62.32	77.74
Shareholders' Equity	1,109	1,079	898.16	748.73	682.08	831.97
Total Liabilities & Equity	4,891	3,592	3,176	3,075	3,342	3,953
Total Debt	1,918	1,477	1,338	1,213	1,226	1,510
Net Cash (Debt)	-937.66	-557.14	-619.18	-671.95	-617.58	-598.01
Net Cash Per Share	-1.95	-1.16	-1.26	-1.35	-1.14	-1.09
Filing Date Shares Outstanding	475.65	482.88	493.85	373.83	366.98	369.6
Total Common Shares Outstanding	475.65	483.75	499.55	371.74	362.91	368.9
Working Capital	1,074	733.52	612.67	264.96	692.58	647.39
Book Value Per Share	1.96	1.86	1.77	1.80	1.71	2.04
Tangible Book Value	-140.81	117.31	167.45	-9.72	-74.91	-89.13
Tangible Book Value Per Share	-0.30	0.24	0.34	-0.03	-0.21	-0.24

Updated Jul 31, 2025. Source: S&P Global Market Intelligence. Capital Markets template. Financial Sources.

SEC Filings: 10-K · 10-Q